Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 6/20 | 0.59 |
| ▸ | MAOA | P21397 | 5/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.59 |
| ▸ | ACHE | P22303 | 3/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | PDE4A | P27815 | 1/20 | 0.59 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.59 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 5/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.59 |
| ▸ | HPGD | P15428 | 4/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30226185 | 0.79 | CYP3A4 (0.65) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL8416177 | 0.79 | CYP3A4 (0.64) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL14096644 | 0.78 | MAOA (0.55) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL4658019 | 0.77 | GAA (0.75) | CYP3A4CYP2D6CYP1A2CYP2C19ACHE | |
| SCHEMBL31238062 | 0.77 | MAOA (0.63) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 | |
| Daphnetin SCHEMBL128212 | 0.75 | MCL1 (1.00) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 | |
| Daphnetin SCHEMBL29612544 | 0.75 | MCL1 (1.00) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 | |
| Methoxsalen SCHEMBL2302069 | 0.75 | CYP3A4 (1.00) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL11253029 | 0.75 | MAOA (0.59) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 | |
| SCHEMBL20278771 | 0.75 | CYP3A4 (0.55) | CYP3A4MAOACYP2D6CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 747 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319055-A1 | COMPOSITIONS FOR TREATING GENITAL HERPES AND METHODS OF THEIR USE | PAGARI LIFE SCIENCE CORP (US) | 2025-10-16 | — | — | US | claimed |
| WO-2025216781-A1 | COMPOSITIONS FOR TREATING GENITAL HERPES AND METHODS OF THEIR USE | PAGARI LIFE SCIENCE CORP (US) | 2025-10-16 | — | — | WO | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| EP-2603098-B1 | METHOD OF IMPROVING STABILITY OF SWEET ENHANCER AND COMPOSITION CONTAINING STABILIZED SWEET ENHANCER | FIRMENICH INCORPORATED (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | claimed |
| CN-119504904-A | A natural polyphenol composition of pericarpium Citri Reticulatae Chachiensis and its preparation method | 中国热带农业科学院农产品加工研究所 | 2025-02-25 | — | — | CN | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| US-20240285660-A1 | COMPOSITION FOR WOUND RELIEF AND INHIBITING A PHD PROTEIN AND METHODS OF TREATMENT | CURAPEP LLC (US) | 2024-08-29 | — | — | US | claimed |
| CN-116574109-A | Preparation method and application of 8-hydroxy psoralen | 河南中烟工业有限责任公司 | 2023-08-11 | — | — | CN | claimed |
| CN-116554192-A | Synthesis method of 8-methoxy psoralen | 河南中烟工业有限责任公司 | 2023-08-08 | — | — | CN | claimed |
| US-20070110851-A1 | Beverage composition and method of preventing degradation of vitamins in beverages | PEPSICO, INC. | 2007-05-17 | — | — | US | claimed |
| EP-1782701-A1 | Beverage composition and method of preventing degradation of vitamins in beverages | PepsiCo, Inc. (US) | 2007-05-09 | — | — | EP | claimed |
| US-20060269494-A1 | New Ubiquitin-Proteasome Regulating Compounds and Their Application in Cosmetic and Pharmaceutical Formulations | GUPTA SHYAM K | 2006-11-30 | — | — | US | claimed |
| US-20050123636-A1 | Use of the total coumarins jof cnidium monnieri in preparation of the medicament for treating psoriasis | YANG LIPING (CN) | 2005-06-09 | — | — | US | claimed |
| CN-1197867-C | Application of fructus Cnidii total coumarin in preparation of medicine for treating psoriasis | YANG LIPING (CN) | 2005-04-20 | — | — | CN | claimed |
| US-20040175732-A1 | Identification of micrornas and their targets | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2004-09-09 | — | — | US | claimed |
| US-20040091589-A1 | Prevention of synthetic color fading in beverages using botanically derived color stabilizers | PEPSICO, INC. | 2004-05-13 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| US-5720304-A | DIAGNOSIS BY CONVENTIONAL MEDICAL TECHNIQUE OR BI-DIGITAL-O-RING TEST; HAVING PATIENT INGEST ANTIBIOTIC OR ANTIVIRAL AGENT, ALSO INGEST A HERB CONCENTRATION OF UMBELLIFERAE FAMILY OVER SUSTAINED PERIOD OF TIME | OMURA YOSHIAKI (US) | 1998-02-24 | — | — | US | claimed |
| CN-1080537-A | The goods of protect against osteoporosis and method for making thereof | MEDICINE TECH DEV CENTRE ZHANJ (CN) | 1994-01-12 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250319055-A1 | COMPOSITIONS FOR TREATING GENITAL HERPES AND METHODS OF THEIR USE | TK1, TYMP, TMSB10 | CYP3A4 3810/4885MAOA 1420/4885CYP2D6 3424/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.